Geert‐Jan Creemers

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 562 citations

Surgical Oncology, Chemotherapy Versus Chemoradiotherapy, Gastrointestinal Oncology +8

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

Bo Jan Noordman, Manon C.W. Spaander, Roelf Valkema et al. · The Lancet Oncology · 2018 · 320 citations

Residual Disease, Surgical Oncology, Esophageal Cancer +11

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial

Charlotte E.L. Klaver, D D Wisselink, Cornelis J.A. Punt et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 312 citations · Full text

Health Sciences, Gastrointestinal Oncology, Medicine +8

Clinical management of women with metastatic breast cancer: a descriptive study according to age group

Klaartje Manders, Lonneke V. van de Poll‐Franse, Geert‐Jan Creemers et al. · BMC Cancer · 2006 · 142 citations · Full text

The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis

Tara M. Mackay, F. Jasmijn Smits, Daphne Roos et al. · HPB · 2019 · 111 citations · Full text

Nationwide Analysis, Surgical Oncology, Pancreatic Cancer +9